SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-022399
Filing Date
2013-01-24
Accepted
2013-01-24 17:25:34
Documents
8
Period of Report
2013-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d472595d8k.htm 8-K 21572
2 UNDERWRITING AGREEMENT d472595dex11.htm EX-1.1 170602
3 OPINION d472595dex51.htm EX-5.1 8916
4 PRESS RELEASE d472595dex991.htm EX-99.1 9652
5 BUSINESS OVERVIEW d472595dex992.htm EX-99.2 23563
6 RISK FACTORS d472595dex993.htm EX-99.3 160415
7 GRAPHIC g472595ex5_1logo.jpg GRAPHIC 5933
8 GRAPHIC g472595g04b55.jpg GRAPHIC 12708
  Complete submission text file 0001193125-13-022399.txt   421835
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21696 | Film No.: 13546410
SIC: 2836 Biological Products, (No Diagnostic Substances)